Assembly of tau in transgenic animals expressing P301L tau: Alteration of phosphorylation and solubility

Journal of Neurochemistry

Volumn 83, Issue 6, 2002, Pages 1498-1508

  Sahara, Naruhiko ^a   Lewis, Jada ^a   DeTure, Michael ^a   McGowan, Eileen ^a   Dickson, Dennis W ^a   Hutton, Mike ^a   Yen, Shu Hui ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

P301L tau; Phosphorylation; Solubility; Transgenic

Indexed keywords

PROTEIN P301L; SERINE; TAU PROTEIN; THREONINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN HOMOGENATE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MALE; MISSENSE MUTATION; MOLECULAR WEIGHT; MOUSE; NEUROFILAMENT; NONHUMAN; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; SOLUBILITY; TRANSGENIC ANIMAL;

AGE FACTORS; AMINO ACID SUBSTITUTION; ANIMALS; BINDING SITES; BRAIN; BRAIN CHEMISTRY; DETERGENTS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; MACROMOLECULAR SUBSTANCES; MALE; MICE; MICE, TRANSGENIC; MUTATION; PHOSPHORYLATION; SARCOSINE; SEX FACTORS; SOLUBILITY; TAU PROTEINS; TAUOPATHIES;

ANIMALIA; MUS MUSCULUS;

EID: 0036904519     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01241.x     Document Type: Article

References (39)

1. Alonso A. C., Grundke-Iqbal I. and Iqbal K. (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med. 2, 783-787.
2. Alonso A., Zaidi T., Novak M., Grundke-Iqbal I. and Iqbal K. (2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc. Natl. Acad. Sci. USA 98, 6923-6928.
3. Arrasate M., Perez M., Armas-Portela R. and Avila J. (1999) Polymerization of tau peptides into fibrillar structures. The effect of FTDP-17 mutations. FEBS Lett. 446, 199-202.
4. Barghorn S., Zheng-Fischhofer Q., Ackmann M., Biernat J., von Bergen M., Mandelkow E. M. and Mandelkow E. (2000) Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. Biochemistry 39, 11714-11721.
5. Brion J. P., Tremp G. and Octave J. N. (1999) Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease. Am. J. Pathol. 154, 255-270.
6. Buee L. and Delacourte A. (1999) Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol. 9, 681-693.
7. Daly N. L., Hoffmann R., Otvos L. Jr and Craik D. J. (2000) Role of phosphorylation in the conformation of tau peptides implicated in Alzheimer's disease. Biochemistry 39, 9039-9046.
8. DeTure M., Ko L. W., Yen S., Nacharaju P., Easson C., Lewis J., van Slegtenhorst M., Hutton M. and Yen S. H. (2000) Missense tau mutations identified in FTDP-17 have a small effect on taumicrotubule interactions. Brain Res. 85, 5-14.
9. Gamblin T. C., King M. E., Dawson H., Vitek M. P., Kuret J., Berry R. W. and Binder L. I. (2000) In vitro polymerization of tau protein monitored by laser light scattering: Method and application to the study of FTDP-17 mutants. Biochemistry 39, 6136-6144.
10. Goedert M., Jakes R., Spillantini M., Hasegawa M., Smith M. J. and Crowther R. A. (1996) Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383, 550-553.
11. Goedert M., Jakes R. and Crowther R. A. (1999) Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments. FEBS Lett. 450, 306-311.
12. Gotz J., Probst A., Spillantini M. G., Schafer T., Jakes R., Burki K. and Goedert M. (1995) Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J. 14, 1304-1313.
13. Gotz J., Chen F., Barmettler R. and Nitsch R. M. (2001) Tau filament formation in transgenic mice expressing P301L tau. J. Biol. Chem. 276, 529-534.
14. Gotz J., Tolnay M., Barmetter R., Chen F., Probst A. and Nitsch R. M. (2001) Oligodendroglial tau filament formation in transgenic mice expressing G272V tau. Eur. J. Neurosci. 13, 2131-2140.
15. Hasegawa M., Smith M. J. and Goedert M. (1998) Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett. 437, 207-210.
16. Hong M., Zhukareva V., Vogelsberg-Ragaglia V., Wszolek Z., Reed L., Miller B. I., Geschwind D. H., Bird T. D., McKeel D., Goate A., Morris J. C., Wilhelmsen K. C., Schellenberg G. D., Trojanowski J. Q. and Lee V. M. (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282, 1914-1917.
17. Hutton M., Lendon C. L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Issacs A., Crover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R. C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J. M., Nowotny P., Petra C., Che L. K., Norton J., Morris J., Reed J., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P. R., Haywood N., Kwok J. B. J., Schofield P. R., Andreadis A., Snowden J., Cravfard D., Neary D., Owen F., Oostra B. A., Hardy J., Goate A., Van Sweiten J., Mann D., Lynch T. and Heutink P. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705.
18. Ishihara T., Hong M., Zhang B., Nakagawa Y., Lee M. K., Trojanowski J. Q. and Lee V. M. (1999) Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24, 751-762.
19. Jicha G. A., Lane E., Vincent I., Otvos L. Jr, Hoffmann R. and Davies P. (1997) A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease. J. Neurochem. 69, 2087-2095.
20. Jicha G. A., Weaver C., Lane E., Vianna C., Kress Y., Rockwood J. and Davies P. (1999) cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease. J. Neurosci. 19, 7486-7494.
21. Kampers T., Friedhoff P., Biernat J., Mandelkow E. E. and Mandelkow E. (1996) RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Lett. 399, 344-349.
22. Kenessey A., Nacharaju P., Ko L. and Yen S. H. (1997) Degradation of tau by lysosomal enzyme cathepsin D: Implication for Alzheimer neurofibrillary degeneration. J. Neurochem. 69, 2026-2038.
23. Kosik K. S., Orecchio L. D., Bakalis S. and Neve R. L. (1989) Developmentally regulated expression of specific tau sequences. Neuron 2, 1389-1397.
24. Lee V. M., Goedert M. and Trojanowski J. Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159.
25. Lewis J., McGowan E., Rockwood J., Melrose H., Nacharaju P., Van Slegtenhorst M., Gwinn-Hardy K., Murphy M., Baker M., Yu X., Duff K., Hardy J., Corral A., Lin W. L., Yen S. H., Dickson D. W., Davies P. and Hutton M. (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25, 402-405.
26. Lewis J., Dickson D. W., Lin W.-L., Chisholm L., Corral A., Jones G., Yen S.-H., Sahara N., Skipper L., Yager D., Eckman C., Hardy J., Hutton M. and McGrowan E. (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487-1491.
27. Miyasaka T., Morishima-Kawashima M., Ravid R., Kamphorst W., Nagashima K. and Ihara Y. (2001) Selective deposition of mutant tau in the FTDP-17 brain affected by the P301L mutation. J. Neuropathol. Exp. Neurol. 60, 872-884.
28. Nacharaju P., Lewis J., Easson C., Yen S., Hackett J., Hutton M. and Yen S. H. (1999) Accelerated filament formation from tau protein with specific FTDP-17 missense mutations. FEBS Lett. 447, 195-199.
29. Pant H. C. V. (1995) Neurofilament phosphorylation. Biochem. Cell Biol. 73, 575-592.
30. Perez M., Valpuesta J. M., Medina M., Montejo de Garcini E. and Avila J. (1996) Polymerization of tau into filaments in the presence of heparin: The minimal sequence required for tau-tau interaction. J. Neurochem. 67, 1183-1190.
31. Poorkaj P., Bird T. D., Wijsman E., Nemens E., Garruto R. M., Anderson L., Andreadis A., Wiederholt W. C., Raskind M. and Schellenberg G. D. (1998) Tau is a candidate gene for chromosome 17 frontotemporal dimentia. Ann. Neurol. 43, 815-825.
32. Probst A., Gotz J., Wiederhold K. H., Tolnay M., Mistl C., Jaton A. L., Hong M., Ishihara T., Lee V. M., Trojanowski J. Q., Jakes R., Crowther R. A., Spillantini M. G., Burki K. and Goedert M. (2000) Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol. (Berl.) 99, 469-481.
33. Rizzu P., Joosse M., Ravid R., Hoogeveen A., Kamphorst W., van Swieten J. C., Willemsen R. and Heutink P. (2000) Mutationdependent aggregation of tau protein and its selective depletion from the soluble fraction in brain of P301L FTDP-17 patients. Hum. Mol. Genet. 9, 3075-3082.
34. Spittaels K., Van den Haute C., Van Dorpe J., Bruynseels K., Vandezande K., Laenen I., Geerts H., Mercken M., Sciot R., Van Lommel A., Loos R. and Van Leuven F. (1999) Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am. J. Pathol. 155, 2153-2165.
35. Tanemura K., Akagi T., Murayama M., Kikuchi N., Murayama O., Hashikawa T., Yoshiike Y., Park J. M., Matsuda K., Nakao S., Sun X., Sato S., Yamaguchi H. and Takashima A. (2001) Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau. Neurobiol. Dis. 8, 1036-1045.
36. Vincent I., Zheng J. H., Dickson D. W., Kress Y. and Davies P. (1998) Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease. Neurobiol. Aging 19, 287-296.
37. Von Bergen M., Biernat J., Mandelkow E.-M. and Mandelkow E. (2001) A hexapeptide motif (306VQ1VYK311)-forming β structure induces the aggregation of tau protein to paired helical filaments. In: Alzheimer's Disease in Etiology, Pathogenesis and Therapeutics (Iqbal K., Sisodia S. S. and Winblad B., eds), pp. 632-640. John Wiley and Sons Ltd, NY, USA.).
38. Weaver C. L., Espinoza M., Kress Y. and Davies P. (2000) Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol. Aging 21, 719-727.
39. Wilson D. M. and Binder L. I. (1997) Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. Am. J. Pathol. 150, 2181-2195.